A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

✍ Scribed by Brian Thiessen; Clinton Stewart; Ming Tsao; Suzanne Kamel-Reid; Paula Schaiquevich; Warren Mason; Jacob Easaw; Karl Belanger; Peter Forsyth; Lynn McIntosh; Elizabeth Eisenhauer

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 359 KB
• Volume: 65
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1041-6